Hexyl-5-aminolaevulinate 0·2% vs. methyl-5-aminolaevulinate 16% daylight photodynamic therapy for treatment of actinic keratoses: results of a randomized double-blinded pilot trial

Abstract
No abstract available
Funding Information
  • Foundation for Clinical Chemistry Research

This publication has 14 references indexed in Scilit: